New ANDA Cases

Winter 2019

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Pfizer Inc. v. Sun Pharm. Indus. Ltd., 18-1529 (D. Del.) Oct. 3, 2018 Hon. Leonard P. Stark Xeljanz XR® (tofacitinib extended-release tablets) 9,937,181
Spectrum Pharms., Inc. v. Fresenius Kabi USA, LLC, 18-1533 (D. Del.) Oct. 3, 2018 Hon. Colm F. Connolly Beleodaq® (belinostat for injection) 6888027
8835501
Bayer Healthcare LLC v. Apotex Inc., 18-1539 (D. Del.) Oct. 4, 2018 Hon. Leonard P. Stark Nexavar® (sorafenib tosylate tablets) 8877933
9737488
Pharmacyclics LLC v. Sun Pharma Global FZE, 18-1543 (D. Del.) Oct. 5, 2018 Hon. Colm F. Connolly Imbruvica® (ibrutinib capsules) 10,004,746
Patheon Softgels Inc. v. PuraCap Pharm. LLC, 18-14693 (D.N.J.) Oct. 5, 2018 Hon. Michael A. Shipp Naproxen Sodium (EQ 200 mg Base) OTC capsules 9,693,978
9,693,979
10,022,344
10,028,925
Celgene Corp. v. Breckenridge Pharm., Inc., 18-14715 (D.N.J.) Oct. 5, 2018 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 9,993,467
Sun Pharma Global FZE v. Teva Pharm. Indus. Ltd., 18-1552 (D. Del.) Oct. 9, 2018 Hon. Richard G. Andrews Yonsa® (abiraterone acetate tablets) 9,889,144
Sumitomo Dainippon Pharma Co., Ltd. v. Alkem Labs. Ltd., 18-14787 (D.N.J.) Oct. 9, 2018 Hon. Stanley R. Chesler Latuda® (lurasidone HCl tablets)) 9815827
9907794
AstraZeneca AB v. Mylan Pharms. Inc., 18-1562 (D. Del.) Oct. 11, 2018 Hon. Colm F. Connolly Symbicort® (budesonide / formoterol fumarate dehydrate inhalation aerosol) 7,759,328
8,143,239
8,575,137
7,967,011
Shionogi Inc. v. Amneal Pharms. LLC, 18-1564 (D. Del.) Oct. 11, 2018 Hon. Mitchell S. Goldberg Fortamet® (metformin HCl extended-release tablets) 6790459
6866866
Par Pharm., Inc. v. Sandoz Inc., 18-14895 (D.N.J.) Oct. 11, 2018 Hon. Brian R. Martinotti Vasostrict® (vasopressin injection) 9,375,478
9,687,526
9,744,209
9,744,239
9,750,785
9,937,223
AstraZeneca AB v. Mylan Pharms. Inc., 18-0193 (N.D.W.V.) Oct. 12, 2018 Hon. Irene M. Keeley Symbicort® (budesonide / formoterol fumarate dehydrate inhalation aerosol) 7,759,328
8,143,239
8,575,137
7,967,011
Teva Pharms. Int’l GMBH v. Fresenius Kabi USA, LLC, 18-1586 (D. Del.) Oct. 15, 2018 Hon. Colm F. Connolly Bendeka® (bendamustine HCl for injection) 10010533
10052385
Galderma Labs., L.P. v. Sun Pharm. Indus. Ltd., 18-1588 (D. Del.) Oct. 15, 2018 Hon. Leonard P. Stark Oracea® (doxycycline capsules) 10,058,564
Anacor Pharms., Inc. v. Lupin Ltd., 18-1606 Oct. 17, 2018 Hon. Leonard P. Stark Kerydin® (tavaborole topical solution) 9,459,938
9,566,289
9,566,290
9,572,823
Valeant Pharms. North America LLC v. Taro Pharms. U.S.A., Inc., 18-15060 (D.N.J.) Oct. 17, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 7,214,506
8,039,494
8,486,978
9,302,009
9,566,272
9,662,394
9,861,698
9,877,955
Millennium Pharms., Inc. v. Hetero Labs Ltd., 18-1639 (D. Del.) Oct. 22, 2018 Hon. Colm F. Connolly Velcade® (bortezomib for injection) 6713446
6958319
Mylan Specialty L.P. v. Aurobindo Pharma USA Inc., 18-15190 (D.N.J.) Oct. 22, 2018 Hon. Freda L. Wolfson AccuNeb® (albuterol sulfate inhaler) 6,702,997
Apotex Inc. v. Gilead Sciences, Inc., 18-6475 (N.D. Cal.) Oct. 23, 2018 Hon. Joseph C. Spero Lexiscan® (regadenoson for injection) 8106183
9085601
Anacor Pharms., Inc. v. Ascent Pharms., Inc., 18-1673 (D. Del.) Oct. 25, 2018 Hon. Richard G. Andrews Kerydin® (tavaborole topical solution) 9,459,938
9,566,289
9,566,290
9,572,823
Helsinn Healthcare S.A. v. Baxter Healthcare Corp., 18-1674 (D. Del.) Oct. 25, 2018 Hon. Richard G. Andrews Aloxi® (palonosetron HCl for injection) 8598219
8729094
Astellas US LLC v. Apotex Inc., 18-1675 (D. Del.) Oct. 25, 2018 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8106183
9085601
Astellas US LLC v. Sandoz Inc., 18-1676 (D. Del.) Oct. 25, 2018 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8106183
9085601
Astellas US LLC v. Sun Pharma Global FZE, 18-1677 (D. Del.) Oct. 25, 2018 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8106183
9085601
Astellas US LLC v. Wockhardt Bio AG, 18-1678 (D. Del.) Oct. 25, 2018 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8106183
9085601
Adapt Pharma Operations Ltd. v. Perrigo UK Finco Ltd. Partnership, 18-15287 (D.N.J.) Oct. 25, 2018 Hon. Jose L. Linares Narcan® (naloxone HCl nasal spray) 9,211,253
9,468,747
9,561,177
9,629,965
9,775,838
AstraZeneca AB v. Teva Pharms. USA, Inc., 18-1685 (D. Del.) Oct. 26, 2018 Hon. Colm F. Connolly Symbicort® (budesonide / formoterol fumarate dehydrate inhalation aerosol) 7,759,328
8,143,239
8,575,137
7,967,011
Boehringer Ingelheim Pharms. Inc. v. Mankind Pharma Ltd., 18-1689 (D. Del.) Oct. 26, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 8551957
9949998
Boehringer Ingelheim Pharms. Inc. v. Lupin Ltd., 18-1690 (D. Del.) Oct. 26, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 8551957
9949998
Anacor Pharms., Inc. v. Mylan Pharms. Inc., 18-1699 (D. Del.) Oct. 29, 2018 Hon. Richard G. Andrews Kerydin® (tavaborole topical solution) 9,459,938
9,566,289
9,566,290
9,572,823
Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00122 (PTAB) Oct. 29, 2018 N/A Lantus® SoloStar® (insulin glargine recombinant for injection)
Apidra® SoloStar® (insulin glulisine recombinant for injection)
Toujeo® (Insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcutaneous solution)
Admelog® Solostar® (insulin lispro for injection)
8,992,486
Sucampo AG v. Sun Pharm. Indus., Ltd., 18-15482 (D.N.J.) Oct. 30, 2018 Hon. Freda L. Wolfson Amitiza® (lubiprostone capsules) 7,795,312
8,097,653
8,389,542
8,026,393
8,338,639
8,779,187
8,748,481
Anacor Pharms., Inc. v. Mylan Pharms. Inc., 18-0202 (N.D.W.V.) Oct. 30, 2018 Hon. Irene M. Keeley Kerydin® (tavaborole topical solution) 9,459,938
9,566,289
9,566,290
9,572,823
Neptune Generics, LLC v. Aventis Pharma S.A., IPR2019-00136 (PTAB) Oct. 31, 2018 N/A Jevtana® Kit (cabazitaxel for injection) 5,847,170
Boehringer Ingelheim Pharms. Inc. v. Alkem Labs. Ltd., 18-1738 (D. Del.) Nov. 2, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
8,551,957
9,949,998
7,713,938
Gilead Sciences, Inc. v. Laurus Labs Ltd., 18-1748 (D. Del.) Nov. 6, 2018 Hon. Richard G. Andrews Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets) 6,642,245
6,703,396
8,592,397
8,716,264
9,457,036
9,744,181
Amneal Pharms. LLC v. Almirall, LLC, IPR2019-00207 (PTAB) Nov. 6, 2018 N/A Aczone® (dapsone topical gel) 9,517,219
Boehringer Ingelheim Pharms. Inc. v. Aurobindo Pharma Ltd., 18-1757 (D. Del.) Nov. 7, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
Synjardy® (empagliflozin / metformin tablets)
Synjardy® XR (empagliflozin / metformin extended-release tablets)
8,551,957
9,949,998
7,713,938
Boehringer Ingelheim Pharms. Inc. v. Laurus Labs Ltd., 18-1758 (D. Del.) Nov. 7, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 7579449
9949998
Boehringer Ingelheim Pharms. Inc. v. Alembic Pharms. Ltd., 18-1762 (D. Del.) Nov. 8, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
Synjardy® (empagliflozin / metformin tablets)
9949998
7713938
Boehringer Ingelheim Pharms. Inc. v. Zydus Pharms. (USA) Inc., 18-1763 (D. Del.) Nov. 8, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Synjardy® (empagliflozin / metformin tablets)
7,579,449
9,949,998
7,713,938
Boehringer Ingelheim Pharms. Inc. v. Macleods Pharms. Ltd., 18-1764 (D. Del.) Nov. 8, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
Synjardy® (empagliflozin / metformin tablets)
8,551,957
9,949,998
7,713,938
Boehringer Ingelheim Pharms. Inc. v. Sun Pharm. Indus. Ltd., 18-1765 (D. Del.) Nov. 8, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
8551957
9949998
Insys Therapeutics, Inc. v. Teva Pharms. USA, Inc. 18-1775 (D. Del.) Nov. 9, 2018 Hon. Colm F. Connolly Subsys® (fentanyl sublingual spray) 10,016,403
Kythera Biopharmaceuticals, Inc. v. Slayback Pharma LLC, 18-16012 (D.N.J.) Nov. 9, 2018 Hon. Brian R. Martinotti Kybella® (deoxycholic acid injection) 8,101,593
8,367,649
8,653,058
Celgene Corp. v. Mylan Pharms. Inc., 18-16035 (D.N.J.) Nov. 9, 2018 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 9,993,467
Pharmacyclics LLC v. Hetero USA Inc., 18-1778 (D. Del.) Nov. 12, 2018 Hon. Colm F. Connolly Imbruvica® (ibrutinib capsules) 8,754,090
9,296,753
9,540,382
9,713,617
9,725,455
Boehringer Ingelheim Pharms. Inc. v. Dr. Reddy’s Labs., Ltd., 18-1779 (D. Del.) Nov. 12, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 9949998
7713938
Dr. Reddy’s Labs., Inc. v. AstraZeneca AB, 18-16057 (D.N.J.) Nov. 12, 2018 Hon. Renee Marie Bumb Nexium® 24HR (esomeprazole magnesium delayed-release oral tablets) 6,428,810
Boehringer Ingelheim Pharms. Inc. v. Aizant Drug Research Solutions PRV. Ltd., 18-1783 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 8551957
9949998
Boehringer Ingelheim Pharms. Inc. v. MSN Labs. Private Ltd., 18-1785 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
Synjardy® XR (empagliflozin / metformin extended-release tablets)
8551957
9949998
Boehringer Ingelheim Pharms. Inc. v. Annora Pharma Private Ltd., 18-1786 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
8,551,957
9,949,997
9,949,998
Boehringer Ingelheim Pharms. Inc. v. Prinston Pharm. Inc., 18-1787 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Glyxambi® (empagliflozin / linagliptin tablets) 8551957
9949998
Boehringer Ingelheim Pharms. Inc. v. Invagen Pharms., Inc., 18-1788 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 9,949,998
Boehringer Ingelheim Pharms. Inc. v. Cipla Ltd., 18-1789 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Synjardy® XR (empagliflozin / metformin extended-release tablets) 9,949,998
Dr. Reddy’s Labs. S.A. v. Indivior UK Ltd., IPR2019-00328 (PTAB) Nov. 13, 2018 N/A Suboxone® (buprenorphine HCl / naloxone HCl film) 9,687,454
Dr. Reddy’s Labs. S.A. v. Indivior UK Ltd., IPR2019-00329 (PTAB) Nov. 13, 2018 N/A Suboxone® (buprenorphine HCl / naloxone HCl film) 9,687,454
Genzyme Corp. v. Apotex Inc., 18-1795 (D. Del.) Nov. 14, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 7,196,205
Genzyme Corp. v. Teva Pharms. USA, Inc., 18-1796 (D. Del.) Nov. 14, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 6,916,802
7,196,205
7,253,185
7,615,573
Medicure Int’l, Inc. v. Gland Pharma Ltd., 18-16246 (D.N.J.) Nov. 16, 2018 Hon. Kevin McNulty Aggrastat® (tirofiban HCl for injection) 6,770,660
Astellas Pharma Inc. v. Xellia Pharms. APS, 18-1818 (D. Del.) Nov. 19, 2018 Hon. Richard G. Andrews Mycamine® (micafungin sodium for injection) 6,774,104
Maia Pharms., Inc. v. Bracco Diagnostics Inc., IPR2019-00345 (PTAB) Nov. 19, 2018 N/A Kinevac® (sincalide for injection) 6,803,046
Genzyme Corp. v. Aizant Drug Research Solutions Private Ltd., 18-1837 (D. Del.) Nov. 20, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 7,196,205
Genzyme Corp. v. Cipla Ltd., 18-1838 (D. Del.) Nov. 20, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 6,916,802
7,196,205
7,253,185
7,615,573
Genzyme Corp. v. Dr. Reddy’s Labs., Inc., 18-1839 (D. Del.) Nov. 20, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 7,196,205
Genzyme Corp. v. Dr. Reddy’s Labs., Inc., 18-16378 (D.N.J.) Nov. 21, 2018 Hon. Brian R. Martinotti Cerdelga® (eliglustat capsules) 7,196,205
Celgene Corp. v. Apotex Inc., 18-16395 (D.N.J.) Nov. 21, 2018 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 9,993,467
AstraZeneca Pharms. LP v. Alkem Labs. Ltd., 18-16399 (D.N.J.) Nov. 21, 2018 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 8,536,206
8,604,064
8,618,142
Leo Pharma A/S v. Perrigo UK Finco Ltd. Partnership, 18-1874 (D. Del.) Nov. 27, 2018 Hon. Colm F. Connolly Finacea® (azelaic acid foam) 10,117,812
BTG Int’l Ltd. v. Qilu Pharm. Co., Ltd., 18-16521 (D.N.J.) Nov. 28, 2018 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets) 8,822,438
Duchesnay Inc. v. Actavis Labs. FL, Inc., 18-1895 (D. Del.) Nov. 29, 2018 Hon. Richard G. Andrews Bonjesta® (doxylamine succinate / pyridoxine HCl extended-release tablets) 9,089,489
9,375,404
9,526,703
9,937,132
Collegium Pharm., Inc. v. Teva Pharms. USA, Inc., 18-1900 (D. Del.) Nov. 30, 2018 Hon. Leonard P. Stark Xtampza® ER (oxycodone extended-release capsules) 9968598
10004729
Duchesnay Inc. v. Actavis Labs. FL, Inc., 18-25015 (S.D. Fla.) Nov. 30, 2018 Hon. Kathleen M. Williams Bonjesta® (doxylamine succinate / pyridoxine HCl extended-release tablets) 9,089,489
9,375,404
9,526,703
9,937,132
Boehringer Ingelheim Pharms., Inc. v. Lupin Atlantis Holdings SA, 18-16708 (D.N.J.) Nov. 30, 2018 Hon. Brian R. Martinotti Spiriva® HandiHaler® (tiotropium bromide inhalation powder) 6,777,423
6,908,928
7,309,707
7,642,268
Bayer Intellectual Property GmbH v. Teva Pharms. USA, Inc., 18-1926 (D. Del.) Dec. 5, 2018 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Genzyme Corp. v. Fresenius Kabi USA, LLC, 18-1934 (D. Del.) Dec. 6, 2018 Hon. Kent A. Jordan Mozobil® (plerixafor for injection) 7897590
6987102
Pfizer Inc. v. Teva Pharms. USA, Inc., 18-1940 (D. Del.) Dec. 7, 2018 Hon. Leonard P. Stark Xeljanz XR® (tofacitinib extended-release tablets) 9,937,181
Adapt Pharma Operations Ltd. v. Perrigo UK Finco Ltd. Partnership, 18-16987 (D.N.J.) Dec. 7, 2018 Hon. Jose L. Linares Narcan® (naloxone HCl nasal spray) 10,085,937
Senju Pharm. Co., Ltd. v. Amneal Pharms. LLC, 18-16991 (D.N.J.) Dec. 7, 2018 Hon. Brian R. Martinotti Prolensa® (bromfenac ophthalmic solution) 10,085,958
Eagle Pharms., Inc. v. Slayback Pharma LLC, 18-1953 (D. Del.) Dec. 11, 2018 Hon. Colm F. Connolly Balrapzo® (bendamustine HCl for injection) 9,265,831
9,572,796
9,572,797
10,010,533
Silvergate Pharms., Inc. v. Bionpharma Inc., 18-1962 (D. Del.) Dec. 12, 2018 Hon. Leonard P. Stark Epaned® (enalapril maleate solution) 9,669,008
9,808,442
10,039,745
Merz Pharms., LLC v. Suven Life Sciences, Ltd., 18-0584 (E.D.N.C.) Dec. 12, 2018 Hon. Terrence W. Boyle Cuvposa® (glycopyrrolate solution) 7638552
7816396
Keryx Biopharmaceuticals, Inc. v. Lupin Ltd., 18-1968 (D. Del.) Dec. 13, 2018 Hon. Leonard P. Stark Auryxia® (ferric citrate tablets) 5,753,706
7,767,851
8,093,423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,328,133
9,757,416
9,387,191
AstraZeneca Pharms. LP v. Chia Tai Tianqing Pharm. Group Co., Ltd., 18-17194 (D.N.J.) Dec. 13, 2018 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection) 6,774,122
7,456,160
8,329,680
8,466,139
Apotex Inc. v. UCB Biopharma SPRL, IPR2019-00400 (PTAB) Dec. 13, 2018 N/A Xyzal® Allergy 24HR (levocetirizine dihydrochloride solution) 8,633,194
Valeant Pharms. North America LLC v. Amneal Pharms. LLC, 18-17246 (D.N.J.) Dec. 14, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Vifor Fresenius Medical Care Renal Pharma Ltd. v. Annora Pharma Private Ltd., 18-1996 (D. Del.) Dec. 17, 2018 Hon. Leonard P. Stark Velphoro® (sucroferric oxyhydroxide chewable tablets) 9,561,251
Abraxis Bioscience, LLC v. HBT Labs, Inc., 18-17304 (D.N.J.) Dec. 17, 2018 Hon. John Michael Vazquez Abraxane® (paclitaxel protein-bound particles for injection) 7,758,891
7,820,788
7,923,536
8,034,375
8,138,229
8,268,348
8,314,156
8,853,260
9,101,543
9,393,318
9,511,046
9,597,409
Valeant Pharms. Int’l v. Sun Pharm. Indus., Ltd., 18-17312 (D.N.J.) Dec. 17, 2018 Hon. Peter G. Sheridan Uceris® (budesonide tablets) 10,064,878
AstraZeneca AB v. Apotex Inc., 18-2010 (D. Del.) Dec. 18, 2018 Hon. Richard G. Andrews Movantik® (naloxegol tablets) 9,012,469
Keryx Biopharmaceuticals, Inc. v. Teva Pharms. USA, Inc., 18-2012 (D. Del.) Dec. 19, 2018 Hon. Leonard P. Stark Auryxia® (ferric citrate tablets) 7,767,851
8,093,423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,328,133
9,387,191
9,757,416
Abraxis Bioscience, LLC v. HBT Labs, Inc., 18-2019 (D. Del.) Dec. 19, 2018 Hon. Richard G. Andrews Abraxane® (paclitaxel protein-bound particles for injection) 7,758,891
7,820,788
7,923,536
8,034,375
8,138,229
8,268,348
8,314,156
8,853,260
9,101,543
9,393,318
9,511,046
9,597,409
Par Pharm., Inc. v. Amphastar Pharms., Inc., 18-2032 (D. Del.) Dec. 20, 2018 Hon. Colm F. Connolly Vasostrict® (vasopressin injection) 9,375,478
9,687,526
9,744,209
9,744,239
9,750,785
9,937,223
Celgene Corp. v. Hetero Labs Ltd., 18-17463 (D.N.J.) Dec. 20, 2018 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,465,800
7,855,217
7,468,363
8,741,929
Valeant Pharms. North America LLC v. Lupin Ltd., 18-17501 (D.N.J.) Dec. 21, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Valeant Pharms. North America LLC v. Perrigo Pharma Int’l DAC, 18-17518 (D.N.J.) Dec. 21, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Eli Lilly and Co. v. Qilu Pharm. Co., Ltd., 18-17554 (D.N.J.) Dec. 24, 2018 Hon. William H. Walls Cialis® (tadalafil tablets) 6,943,166
AstraZeneca AB v. MSN Pharms., Inc., 18-2051 (D. Del.) Dec. 26, 2018 Hon. Richard G. Andrews Movantik® (naloxegol tablets) 9,012,469
Janssen Products, L.P. v. Amneal Pharms. LLC, 18-17585 (D.N.J.) Dec. 26, 2018 Hon. William H. Walls Prezista® (darunavir tablets) 8,518,987
7,126,015
7,595,408
Biogen Int’l GMBH v. Banner Life Sciences LLC, 18-2054 (D. Del.) Dec. 27, 2018 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules)
Bafiertam® (dimethyl fumarate delayed-release capsules)
7,619,001
Valeant Pharms. North America LLC v. Alkem Labs. Ltd., 18-17731 (D.N.J.) Dec. 28, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Valeant Pharms. North America LLC v. Aurobindo Pharma USA Inc., 18-17733 (D.N.J.) Dec. 28, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Back to Top